Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Lemtrada 12mg Infusion

Prescription Icon
Prescription Required

Marketer

Sanofi India Ltd

Salt Composition

Alemtuzumab (12mg)

Overview Lemtrada 12mg Infusion

Alembic's Lemtrada (12mg infusion) treats chronic lymphocytic leukemia and multiple sclerosis. It targets cancerous cells for immune system elimination and modifies immune responses to reduce nervous system damage. Administered under medical supervision, dosage and frequency are individualized based on your condition and may adjust over time. Strictly adhere to your doctor's instructions; incorrect usage can lead to severe complications. Therapeutic effects might take weeks or months; discontinue only with your physician's approval. Common side effects include rash, headache, and sleep disturbances. The medication can lower white blood cell counts, increasing infection and bleeding risks. Report fever, chills, cough, mouth sores, breathing difficulties, unusual bleeding or bruising, or blood in urine immediately. Post-infusion monitoring is crucial due to potential life-threatening reactions like chest pain, shortness of breath, and irregular heartbeat. Inform your doctor of pre-existing heart, liver, or kidney conditions, and all other medications (including infection treatments) before commencing treatment, as interactions are possible. Avoid pregnancy during treatment; effective contraception for both partners is essential.

Uses of Lemtrada 12mg Infusion

Chronic lymphocytic leukemia and multiple sclerosis

Major Benefits of Lemtrada 12mg Infusion:

This medication will be administered by your healthcare provider. Self-medication is not advised.

Common Side effects of Lemtrada 12mg Infusion:

  • Rash
  • Headache
  • Insomnia (difficulty in sleeping)
  • Nausea
  • Upper respiratory tract infection
  • Decreased white blood cell count
  • Fatigue
  • Fever
  • Itching
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Hives
  • Decreased white blood cell count (lymphocytes)

How to use Lemtrada 12mg Infusion:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Lemtrada 12mg Infusion works:

Lemtrada, a 12mg infusion, is a targeted monoclonal antibody therapy. This treatment identifies cancerous cells, marking them for elimination by the patient's own immune defenses. Simultaneously, it regulates immune system activity to prevent harm to the nervous system.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Lemtrada 12mg Infusion may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Lemtrada 12mg Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Lemtrada 12mg Infusion while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Treatment with Lemtrada 12mg infusion can lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding Lemtrada 12mg infusion use in patients exhibiting renal impairment is scarce. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Lemtrada 12mg Infusion use in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Lemtrada 12mg Infusion :

Forgetting a scheduled Lemtrada 12mg infusion requires immediate physician consultation.

Facts to Know About Lemtrada 12mg Infusion

LabelValue
Chemical Category Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Drugs
Action Class Anti-CD52 Therapies

FAQs on Lemtrada 12mg Infusion

Continue this medication precisely as prescribed until your physician instructs otherwise. Regular imaging will monitor the tumor's response, with scheduling determined by your doctor.
Lemtrada 12mg Infusion reduces white blood cells and platelets, increasing your infection and bleeding risk. Avoid contact with sick individuals. Report any suspected infection (fever, chills, cough) or bleeding to your doctor immediately. Use caution with sharp objects and a soft-bristled toothbrush to minimize bleeding.
To ease nausea, try eating smaller, more frequent meals. Avoid salty, spicy, fried, or fatty foods. Sucking on lozenges or chewing gum can also help. Your doctor may prescribe anti-nausea medication for faster relief.
Moisturizer can soothe rashes, dryness, and itching. This medication may cause brittle, patchy, or thinning hair, but these effects usually disappear after treatment ends.
This medication may cause tingling, numbness, pain, or burning in your arms or legs. Reduced sensation may impair balance and coordination, increasing your fall risk. Report these symptoms to your doctor; your dosage or treatment schedule may require adjustment.
Your physician will order blood tests to assess your blood cell counts and the function of your liver and kidneys.
This treatment poses a risk to a developing fetus. Avoid pregnancy (for both men and women) during treatment and for at least six months following its completion. Discuss reliable contraception with your doctor before beginning treatment.
Avoid breastfeeding during and for four months after your final dose of Lemtrada 12mg Infusion, as it may transfer into breast milk and potentially harm your infant.
Avoid live vaccines during and for up to 12 months after treatment with this medication. Your doctor will advise on the exact duration depending on your specific therapy.
Seek immediate medical attention for mouth or throat swelling, breathing difficulties, severe weakness, an irregular, fast, or slow heartbeat, chest pain, or a severe rash.
Lemtrada 12mg Infusion
5,35,691
MRP 6,20,000
13% off